Literature DB >> 21299442

The role of cytokines in the regulation of drug disposition: extended functional pleiotropism?

Neill James Liptrott1, Andrew Owen.   

Abstract

INTRODUCTION: Drug disposition, metabolism and drug-drug interactions are important considerations for most drugs. Cytokines are integral to the successful resolution of many diseases. Data are emerging on a role for cytokines in regulation of the expression and activity of drug transporters and drug metabolising enzymes. Investigation of the interaction between pharmacological and immunological responses is key to understanding the complex relationships involved in patient response to therapy. AREAS COVERED: Evidence detailing the ability of cytokines to regulate drug disposition and metabolism is reviewed in the context of different cell and tissue types. The literature search undertaken provides an overview of the current understanding of the interrelationship between pharmacological and immunological factors which may influence successful drug therapy. EXPERT OPINION: Dysregulation of cytokines and cytokine networks is a hallmark of a number of diseases such as HIV and cancer. The mechanisms by which the immune system can influence drug disposition are relatively understudied but recent work has highlighted the necessity for examining its impact on pharmacokinetics and pharmacodynamics. A more comprehensive approach in clinical studies will allow better determination of the impact of cytokines on drug disposition. In addition, determining the mechanisms that underpin the differential effects of cytokines across different cell types will clarify the responses reported in these studies.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21299442     DOI: 10.1517/17425255.2011.553600

Source DB:  PubMed          Journal:  Expert Opin Drug Metab Toxicol        ISSN: 1742-5255            Impact factor:   4.481


  5 in total

1.  A randomised study of the effect of danoprevir/ritonavir or ritonavir on substrates of cytochrome P450 (CYP) 3A and 2C9 in chronic hepatitis C patients using a drug cocktail.

Authors:  Peter N Morcos; Linda Chang; Rohit Kulkarni; Mylene Giraudon; Nancy Shulman; Barbara J Brennan; Patrick F Smith; Jonathan Q Tran
Journal:  Eur J Clin Pharmacol       Date:  2013-07-20       Impact factor: 2.953

2.  Immunological response as a source to variability in drug metabolism and transport.

Authors:  Hege Christensen; Monica Hermann
Journal:  Front Pharmacol       Date:  2012-02-10       Impact factor: 5.810

3.  Staphylococcus aureus and Lipopolysaccharide Modulate Gene Expressions of Drug Transporters in Mouse Mammary Epithelial Cells Correlation to Inflammatory Biomarkers.

Authors:  Yagmur Yagdiran; Jonas Tallkvist; Karin Artursson; Agneta Oskarsson
Journal:  PLoS One       Date:  2016-09-01       Impact factor: 3.240

4.  Nodal is involved in chemoresistance of renal cell carcinoma cells via regulation of ABCB1.

Authors:  Xingwang Zhu; Dongwei Xue; Jia Liu; Fengming Dong; Yongzhi Li; Yili Liu
Journal:  J Cancer       Date:  2021-02-02       Impact factor: 4.207

5.  Systemic Lupus Erythematosus Activity Affects the Sinusoidal Uptake Transporter OATP1B1 Evaluated by the Pharmacokinetics of Atorvastatin.

Authors:  Roberta Natália Cestari; Renê Donizeti Ribeiro de Oliveira; Flávio Falcão Lima de Souza; Leandro Francisco Pippa; Glauco Henrique Balthazar Nardotto; Adriana Rocha; Eduardo Antônio Donadi; Vera Lucia Lanchote
Journal:  Clin Transl Sci       Date:  2020-05-28       Impact factor: 4.689

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.